DALLAS, April 17, 2020 /PRNewswire/ -- Puration, Inc. (USOTC: PURA) today announced entering into initial due diligence engagements with three prospective CBD business acquisition candidates. The Company has recently announced an increase in its pipeline of potential acquisitions fueling an acquisition campaign launched earlier this year backed by a recent $5 million investment. Management believes the general business pressure resulting from the Coronavirus economic conditions accounts for the increase in potential acquisitions.
For more information on Puration, visit http://www.purationinc.com
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Puration, Inc.Brian Shibley,
SOURCE Puration, Inc.